,mitocore,293,mitoparp,293 + high NAD,mitoparp + high NAD,293 + low NAD,mitoparp + low NAD,subsystem
1PPDCRc_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
1PPDCRc_NADPH_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
2AMADPTmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
2AMADPTmC_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
2HBO,-0.016999999999999005,-0.016999999999995453,-0.016999999999995453,-0.016999999999995453,-0.017,-0.0109929328621879,-0.0109929328621879,Threonine and Methionine degradation
2HBt2,-0.017000000000096563,-0.017,-0.017,-0.017,-0.017,-0.0109929328621879,-0.0109929328621879,Boundary Conditions - Biomarkers
2OXOADOXm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan / Lysine Metabolism 
2OXOADPTmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
2OXOADPTmC_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
34HPPOR,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tyrosine degradation
3HAO,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
3HBCOAHLm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Valine degradation
3SALATAi,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation I
3SPYRSP,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation I
4ABUTtm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,GABA shunt - transport
4aabutn_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Arginine degradation
5AOPtm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
AACTOORm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glycine degradation
AASAD3m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
ABTArm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,GABA shunt
ABUTD,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
ACACT10m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Isoleucine degradation
ACACT1rm,-1.2725,-1.1984673913043478,-1.2463768115942033,-1.1984673913043478,-1.2463768115942038,-0.5604710494605729,-0.5813334675665872,FA and ketone body metabolism / Ketogenesis
ACACt2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - core
ACACt2mB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
ACADLC14_MitoCore,0.27615281967969013,0.2841725407356587,0.2792392555862951,0.28417254073565784,0.27923925558629503,0.24491407312985192,0.20818472069813368,FA metabolism
ACADLC16_MitoCore,0.27615281967971267,0.2841725407356587,0.27923925558629525,0.28417254073565795,0.2792392555862952,0.2449140731298522,0.20818472069813512,FA metabolism
ACALDtm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ACCOAC,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
ACCOALm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Propanoate metabolism
ACITL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Reductive carboxylation / Acetyl-CoA production for biosynthesis
ACITLm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
ACOAHi,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Acetate production
ACOATA,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
ACONT,-74.75958486539504,-74.74622384710928,-74.65281676949134,-74.74622384710914,-74.65281676949127,-53.0534641426574,-49.300394676843624,Reductive carboxylation
ACONTm,-67.79747308152724,-67.77798178482385,-67.82742546514343,-67.77798178482375,-67.82742546514342,-48.00622683585833,-44.32634909994696,TCA cycle
ACOT2_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
ACS,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ACSm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ACt2r,-0.01,0.0,-0.01,0.0,-0.01,0.0,-0.01,Boundary Conditions - Biomarkers
ADK1,0.277031972576097,0.2842607946291196,0.28013726840869646,0.2842607946292156,0.28013726840869424,0.24491407312980681,0.2081847206981351,Cytosolic misc
ADK1m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
ADNK1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Methionine degradation
ADSL1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Purine Nucleotide Cycle
ADSS,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Purine Nucleotide Cycle
AGMTm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Arginine degradation
AGPAT1B_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
AHC,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Methionine degradation
AKGDm,0.0,0.0,4.423488478764553,0.0,4.423488478764554,0.17455853830207854,2.7226185071533444,TCA cycle
AKGMALtm,-4.1855,-0.6639999999999909,-4.052,-0.6640000000000001,-4.052,-0.5405821326172504,-2.243093959159792,Malate aspartate shuttle
AKGt_MitoCore,-1.918000000000001,-1.9180000000000024,-1.917999999999998,-1.9179999999999977,-1.9180000000001056,-1.3083018028323452,-1.6068343929805984,Boundary Conditions - Biomarkers
ALASm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
ALATA_L,-0.20299999999999274,-0.20299999999999563,-0.203,-0.20299999999999072,-0.2030000000000003,-0.20285882352941437,-0.20285882352941176,Cytosolic misc
ALAt2r,-0.3200000000000655,-0.312,-0.312,-0.312,-0.3120000000001081,-0.25129106630861925,-0.25129106630862186,Boundary conditions - nonessential amino acids
ALCD2if,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ALCD2yf,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ALDD2x,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ALDD2xm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Alcohol metabolism
AMCOXO,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
AMCOXO2_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
AMPD1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Purine Nucleotide Cycle
AMPTASECG,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glutathione degradation
AOBUTDsm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glycine degradation
APAT2rm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Beta-alanine degradation
APRTO2m_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Arginine degradation
ARGDCm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Arginine degradation
ARGN,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Urea Cycle
ARGNm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Urea Cycle
ARGSL,-0.007,-0.007,-0.007,-0.007,-0.007,-0.007,-0.007,Urea Cycle
ARGSS,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Urea Cycle
ARGSUCt_MitoCore,-0.11233333333333184,-0.10966666666666425,-0.10966666666666669,-0.10966666666666665,-0.10966666666666669,-0.08943035543620892,-0.08943035543620638,Boundary Conditions - Biomarkers
ARGtiDF,-0.10533333333335516,-0.10266666666666666,-0.10266666666666668,-0.10266666666666667,-0.10266666666670214,-0.08243035543620536,-0.0824303554362058,Boundary conditions - nonessential amino acids
ARGtmB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
ASNS1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Asparagine synthesis
ASNtm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
ASP1DC,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Beta-alanine synthesis
ASPGLUmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Malate aspartate shuttle
ASPTA,-0.166,-0.158,-0.15799999999999997,-0.15799999999999545,-0.15799999999999997,-0.09729106630862516,-0.09729106630861929,Malate aspartate shuttle
ASPTAm,-4.459000000000023,-4.443000000000065,-4.442999999999995,-4.4429999999997625,-4.442999999999998,-4.09091919774834,-4.090919197748268,Malate aspartate shuttle
ASPte,-0.154,-0.154,-0.154,-0.154,-0.154,-0.154,-0.154,Boundary conditions - nonessential amino acids
ATPtmB_MitoCore,-922.4171107519617,-922.4167360230203,-920.5439776042731,-922.4167360230203,-920.5439776042731,-945.829326142073,-948.1047123298118,Mitochondrial transporters - characterised
BALAtmr,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
BDHm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Ketone bodies - degradation
BHBt,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - core
BHBtmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
BILIRED,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Degradation
BILIRED2_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Degradation
BUTt2mB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
BUTt2r,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
Biomass_MitoCore,-100.89230387215594,-100.87424844203966,-100.88218482363732,-100.87424844203997,-100.8821848236372,-71.56378433296844,-66.49206883862234,Boundary conditions - core
Biomasst_MitoCore,-8.581469193122876,-8.572643578301296,-0.009302325581395349,-8.572643578301543,-0.009302325581395349,-5.355140158491109,-0.009302325581395349,Mitochondrial transport - diffusion / artificial
C160CPT1,0.27615281967969013,0.28417254073565323,0.27923925558629537,0.2841725407356661,0.2792392555862951,0.2449140731298606,0.20818472069813368,Carnitine shuttle
C160CPT2,0.27615281967969013,0.2841725407356587,0.27923925558629537,0.28417254073565784,0.2792392555862951,0.24491407312985192,0.20818472069813368,Carnitine shuttle
CBPSam,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Citrulline biosynthesis
CDSm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
CHLtmB_MitoCore,-3.0893289095242156,-3.0861516881884814,0.0,-3.0861516881885014,0.0,-1.927850457056789,0.0,Mitochondrial transporters - uncharacterised
CHOLtu,-3.0893289095242524,-3.0861516881885365,0.0,-3.0861516881885196,0.0,-1.9278504570566417,0.0,Boundary Conditions - Biomarkers
CIII_MitoCore,31.21824425260411,31.226572930108585,31.225937670897732,31.226572930108826,31.225937670897736,22.10176832715728,20.42617072983651,Electron transport chain
CII_MitoCore,3.9100098333946645,3.9719897726842857,3.967987965532726,3.971989772684282,3.967987965532729,2.6907535273115535,2.176541942764037,Electron transport chain
CITtamB,-6.28428571428568,-2.5559999999999974,-6.214285714285717,-2.5559999999999956,-6.214285714285541,-2.4397941476361735,-3.6220952869196674,Mitochondrial transporters - characterised
CITtbm,-1.9180000000000013,-1.9179999999999957,0.0,-1.9180000000000001,0.0,-1.91785882352933,0.0,Mitochondrial transporters - characterised
CIV_MitoCore,15.609122126302017,15.613286465054342,15.612968835448866,15.613286465054413,15.612968835448868,11.050884163578637,10.213085364918255,Electron transport chain
CI_MitoCore,10.04710491549202,10.035054827288084,10.039586746913814,10.035054827287986,10.039586746913823,6.8451963397305295,6.718587016366689,Electron transport chain
CK,-922.4171107519619,-922.4167360230207,-920.5439776042731,-922.4167360230205,-920.5439776042731,-945.8293261420728,-948.1047123298117,Creatine ATP buffer
CKc,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Creatine ATP buffer
CLPN_MitoCore,-0.01,-0.01,0.0,-0.01,0.0,-0.01,0.0,Cardiolipin synthesis
CLS_hsm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
CO2t,-18.394260869565215,-18.34608695652177,-18.36417391304356,-18.346086956521937,-18.364173913043462,-13.461538465034069,-11.966066114290841,Boundary conditions - core
CO2tm,-18.457173913043476,-18.423086956521676,-18.35633695652167,-18.4230869565217,-18.356336956521673,-12.429883442848835,-11.446601844482716,Mitochondrial transport - diffusion / artificial
COAtmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
COAtmC_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
COt,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
CPPPGO,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
CREATtmdiffir,-922.4171107519618,-922.4167360230203,-920.5439776042731,-922.4167360230206,-920.543977604273,-945.8293261420729,-948.1047123298116,Mitochondrial transport - diffusion / artificial
CSm,5.2138358616819955,5.2730148356441,5.283127665074408,5.273014835644098,5.283127665074413,3.6647627709523976,3.388221568519924,TCA cycle
CV_MitoCore,73.1502126629423,73.13698571015357,73.14316090238789,73.13698571015357,73.14316090238788,52.15013358021635,48.13908505152769,Electron transport chain
CYANt,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
CYANtm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transport - diffusion / artificial
CYSO,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation I
CYSTA,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation II
CYSTAm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation II
CYSTGL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Methionine and Serine degradation
CYSTS,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Methionine and Serine degradation
CYStec,-0.004999999999920877,-0.005,-0.005,-0.005,-0.005,-0.005,-0.005000000000002558,Boundary conditions - nonessential amino acids
CYTK1m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
DHFR,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Folate cytosolic
DHPR,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Phenylalanine degradation
ECOAH12m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Valine degradation
ECOAH1m,-1.1081666666666665,-1.036,-1.0843043478260919,-1.036,-1.0843043478260876,-0.3981654174205221,-0.41902783552653744,FA metabolism
ECOAH9m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Isoleucine degradation
ENO,-1.549999999999991,-1.1424999999999947,-0.3219999999999955,-1.1424999999999743,-0.32199999999999995,-0.22135492520295774,-0.2612910663086193,Glycolysis/gluconeogenesis
ETOHt,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
EX_2hb_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_HC00250_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_ac_e,-0.01,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_acac_e,-0.114,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_akg_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_ala_B_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_ala_L_e,-0.01,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_arg_L_e,-0.007,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_argsuc_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_asn_L_e,-0.01,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_asp_L_e,-0.154,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_bhb_e,-0.048,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_bilirub_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_biomass_e,80.71384309772483,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_but_e,-0.006,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_chol_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_cit_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_citr_L_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_co2_e,9.704470479288597,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_co_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_creat_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_cyan_e,-0.0059999999999860165,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_cys_L_e,-0.001,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_etoh_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_fe2_e,-0.08887500000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_fol_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_for_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_fum_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_glc_D_e,-0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_gln_L_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_glu_L_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_gly_e,-0.009,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_glyc_e,-0.01,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_h2o_e,-2.643046543164175,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_h_e,-4.350408647747671,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_hco3_e,-1.71,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_hdca_e,-1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_his_L_e,-0.01,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_icit_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_ile_L_e,-0.004,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_lac_L_e,-0.575,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_leu_L_e,-0.016,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_lys_L_e,-0.03,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_mal_L_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_mercplac_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_met_L_e,-0.005,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_nad_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_nadh_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_nh4_e,-0.32199999999999684,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_no_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_o2_e,-19.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_oaa_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_pchol_hs_e,-6.521916586773433,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_pcreat_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_pe_hs_e,-2.9176995256617997,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_phe_L_e,-0.012,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_pi_e,-0.31010864236102886,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_ppa_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_pro_L_e,-0.004,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_ps_hs_e,-2.5744407579368827,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_ser_L_e,-0.017,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_so3_e,-0.0059999999999959105,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_succ_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_tcynt_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_thr_L_e,-0.012,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_trp_L_e,-0.008,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_tsul_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_tyr_L_e,-0.011,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_urea_e,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EX_val_L_e,-0.011,0.0,0.0,0.0,0.0,0.0,0.0,0.0
FA160ACPH,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
FACOAL160i,0.27615281967969013,0.28417254073565323,0.27923925558629537,0.2841725407358427,0.2792392555862951,0.24491407312983393,0.2081847206981351,Carnitine shuttle
FACOAL40im,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Butanoate metabolism
FBA,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glycolysis/gluconeogenesis
FBP,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Gluconeogenesis
FCLTm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
FE2t,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
FE2tm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
FKYNH,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
FOLR2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Folate cytosolic
FOLt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
FORt2mB_MitoCore,-0.008,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
FORt_MitoCore,-0.008,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
FTCD,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Folate cytosolic
FTHFDH,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Folate cytosolic
FTHFDHm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Folate mitochondrial
FTHFL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Folate cytosolic
FTHFLm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Folate mitochondrial
FUM,-1.8949999999999751,-1.8949999999999056,-1.8949999999999987,-1.8950000000000877,-1.8949999999999982,-1.6831541828751386,-1.8950000000000002,Cytosolic misc
FUMAC,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tyrosine degradation
FUMm,-34.17275422608932,-34.186400193022074,-34.14463988768042,-34.18640019302222,-34.14463988768038,-24.221653026380757,-23.061444832385096,TCA cycle
FUMt_MitoCore,-1.9179999999999993,-1.917999999999988,-1.9179999999999995,-1.9180000000000048,-1.918000000000108,-1.7060130064044505,-1.9178588235294103,Boundary Conditions - Biomarkers
FUMtmB_MitoCore,-41.02214553043649,-41.01480431159832,-41.01803119202793,-41.01480431159818,-41.01803119202788,-29.097362860655494,-27.03523678054107,Mitochondrial transporters - uncharacterised
G3PD1,-4.449000000000023,-4.4329999999999945,-4.432999999999995,-4.433,-4.433,-4.081200887889084,-4.081200887889121,Glycerol phosphate shuttle
G5SADrm,-0.004,-0.004,-0.004,-0.004,-0.004,-0.004,-0.004,Proline degradation/synthesis
G5SDym,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Proline synthesis
G6PDH2r,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Pentose phosphate pathway
G6PPer,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Gluconeogenesis
GAPD,-1.2199999999999953,-0.8204999999999982,0.0,-0.8205,0.0,0.016056164574682397,0.0,Glycolysis/gluconeogenesis
GCCam,-0.3600000000000001,-0.34400000000000286,-0.34400000000000003,-0.3440000000000002,-0.34400000000000003,-0.1859063829787235,-0.1859063829787234,Glycine cleavage system (GCS)
GCCbim,-0.36,-0.3440000000000002,-0.34400000000000003,-0.3440000000000002,-0.34400000000000003,-0.1859063829787235,-0.1859063829787234,Glycine cleavage system (GCS)
GCCcm,-0.36,-0.3440000000000002,-0.34400000000000003,-0.3440000000000002,-0.34400000000000003,-0.1859063829787235,-0.1859063829787234,Glycine cleavage system (GCS)
GHMT2r,-0.018000000000000002,-0.01,-0.01,-0.01,-0.01,-0.009,-0.009,Serine and glycine biosynthesis
GHMT2rm,-0.35900000000000004,-0.1323333333333374,-0.34299999999999997,-0.13233333333333347,-0.343,-0.0715163120567376,-0.1853659574468086,Serine and glycine biosynthesis
GLCt1r,0.0,0.0,0.0,0.0,0.0,0.009744124135521948,0.0,Boundary conditions - core
GLNS,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glutamine synthesis
GLNtm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
GLU5Km,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Proline synthesis
GLUCYS,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glutathione synthesis
GLUDC,0.0,0.0,0.0,0.0,0.0,0.0,0.0,GABA shunt
GLUDxi,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis - cytosolic
GLUDxm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis
GLUDy,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis - cytosolic
GLUDym,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis
GLUN_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glutamine degradation - cytosolic
GLUNm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glutamine degradation
GLUt2mB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
GLUt_MitoCore,-0.32999999999999546,-0.322,-0.322,-0.322,-0.32200000000000106,-0.2612910663086203,-0.261291066308619,Boundary conditions - nonessential amino acids
GLYATm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glycine degradation
GLYC3Ptm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
GLYCt,-0.01,-0.01,-0.01,-0.01,-0.01,-0.01,-0.01,Boundary conditions - alternative fuels
GLYCtm,-1.4927149345645916,-1.4911794077385163,0.0,-1.4911794077385492,0.0,-0.9345627605002215,0.0,Mitochondrial transport - diffusion / artificial
GLYK,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
GLYOXm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glycine degradation
GLYt2r,-0.702,-0.678,-0.678,-0.678,-0.6780000000001618,-0.43707104168832894,-0.4591974492873427,Boundary conditions - nonessential amino acids
GLYtm,-0.7199999999997928,-0.6879999999996835,-0.6879999999997968,-0.688,-0.6879999999997928,-0.371812765957447,-0.3718127659574468,Mitochondrial transporters - uncharacterised
GND,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Pentose phosphate pathway
GPAMm_hsB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
GTHO,0.0,0.0,0.0,0.0,0.0,0.0,0.0,ROS defense
GTHOm,0.010047104915492237,0.010035054827288262,0.010039586746913758,0.010035054827288207,0.010039586746914018,0.00684519633973181,0.006718587016366727,ROS defense
GTHP,0.0,0.0,0.0,0.0,0.0,0.0,0.0,ROS defense
GTHPm,0.010047104915492237,0.010035054827288262,0.010039586746913758,0.010035054827288207,0.010039586746914018,0.00684519633973181,0.006718587016366727,ROS defense
GTHS,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glutathione synthesis
GluForTx,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Histidine degradation
H2Ot,-17.89608231707311,-16.99573913043504,-17.01991304347827,-16.99573913043473,-17.019913043478454,-13.127618741121182,-12.040838704053783,Boundary Conditions - Misc
H2Otm,-135.52430566540048,-135.4610903034096,-135.46436225368862,-135.46109030341054,-135.46436225368845,-97.70539796418134,-89.92453052774472,Mitochondrial transport - diffusion / artificial
HACD1m,-1.1081666666666665,-1.036,-1.0843043478260919,-1.036,-1.0843043478260876,-0.3981654174205221,-0.41902783552653744,FA metabolism
HACD9m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Isoleucine degradation
HCO3t_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - core
HDCAtm_MitoCore,-0.7116913506355036,-0.7032446396410904,-0.708091207472804,-0.7032446396410779,-0.7080912074727836,-0.7418130216540832,-0.7911272496314075,Boundary conditions - core
HDCAtr,0.2755746967857047,0.2841725407356729,0.2792392555862787,0.2841725407356226,0.27923925558628127,0.24491407312984503,0.1947174892829946,Boundary conditions - core
HEX1,0.0,0.0,0.0,0.0,0.0,0.009744124135463661,0.0,Glycolysis
HGNTOR,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tyrosine degradation
HIBDm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Valine degradation
HISD,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Histidine degradation
HIStiDF,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
HKYNH,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
HMBS,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
HMGCOASim,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Ketogenesis
HMGLm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Ketogenesis / Leucine degradation
HOXG,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Degradation
Hct_MitoCore,-3.7471183592882444,-3.6901564782277974,-1.9091356029503872,-3.6901564782278715,-1.9091356029505189,-1.879738195607365,-2.0028940377884807,Boundary Conditions - Misc
Hmt_MitoCore,-416.68673442885444,-416.665073388438,-416.5691818481032,-416.665073388447,-416.5691818481072,-296.8689288975014,-275.07805975504834,Boundary Conditions - Misc
HtmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
ICDHxm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle
ICDHy,-0.1,-0.1,-0.1,-0.1,-0.1,-0.0962637362637363,-0.0962637362637363,Reductive carboxylation
ICDHyrm,-75.09951983911745,-75.05917426191188,-2.2126406643662255,-75.0591742619119,-2.212640664366226,-53.817673603438436,-1.758232581617189,TCA cycle
ICITt_MitoCore,-1.9179999999999997,-1.9180000000002542,-1.9179999999999955,-1.9179999999999988,-1.9180000000001094,-1.1541747364954986,-1.4143764546481554,Boundary Conditions - Biomarkers
ILETAm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Isoleucine degradation
ILEt5m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
ILEtec,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
IZPN,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Histidine degradation
KYN3OX,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
LDH_Dm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glycine degradation
LDH_L,-2.4550000000000116,-2.0554999999999892,-2.087499999999995,-2.0554999999999977,-2.0875,-1.329174911660769,-1.349867491166074,Glycolysis/gluconeogenesis
LEUTAm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Leucine degradation
LEUt5m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
LEUtec,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
LGTHLm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glycine degradation
LPCOXc_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
LYSOXc_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
LYStiDF,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
LYStmB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
L_LACt2r,-2.4549999999999947,-2.0555000000001016,-2.087500000000076,-2.0554999999999994,-2.0874999999999995,-1.329174911660769,-1.349867491166074,Boundary conditions - core
MACACI,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tyrosine degradation
MALSO3tm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
MALSO4tm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
MALTSULtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
MAL_Lte,-1.918,-1.917999999999806,-1.918,-1.918,-1.9180000000001156,-1.7060130064044727,-1.917858823529412,Boundary Conditions - Biomarkers
MALtm,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
MCCCrm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Leucine degradation
MCLOR,-0.005999999999999329,-0.0059999999999967805,-0.0059999999999954525,-0.0059999999999954525,-0.006,-0.00387985865724173,-0.00387985865724087,Cysteine degradation II
MCOATA,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
MCPST,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation II
MCPSTm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation II
MDH,-2.7210000000000005,-2.705,-2.705,-2.7049999999999956,-2.705,-2.3457071827294964,-2.345707182729491,Malate aspartate shuttle
MDHm,3.7715408715589005,3.80855321439416,3.8090076203974554,3.8085532143942737,3.8090076203974546,2.1892990320109664,1.8986708509750732,TCA cycle
ME1m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
ME2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cytosolic misc
ME2m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
MECR14C_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
MECR16C_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
MERCPLACt_MitoCore,-0.005999999999938609,-0.006,-0.006,-0.006,-0.006,-0.00387985865724173,-0.00387985865724087,Boundary Conditions - Biomarkers
METAT,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Methionine degradation
METAT2_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Methionine degradation
METtec,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
MGCHrm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Leucine degradation
MMCDm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Propanoate synthesis
MMEm,-0.031999999999996476,0.0,-0.03199999999999559,0.0,-0.03199999999999924,0.0,-0.01376512114131106,Propanoate metabolism
MMMm,-1.918,0.0,-1.9179999999999975,0.0,-1.9179999999999997,0.0,-1.584222204348158,Propanoate metabolism
MMSAD1m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Propanoate metabolism
MMSAD3m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Beta-alanine degradation
MMSAD3m2_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Beta-alanine degradation
MTHFC,-0.008,0.0,0.0,0.0,0.0,0.0,0.0,Folate cytosolic
MTHFCm,-0.008,0.0,0.0,0.0,0.0,0.0,0.0,Folate mitochondrial
MTHFD,-0.018000000000000002,-0.01,-0.01,-0.01,-0.01,-0.009,-0.009,Folate cytosolic
MTHFD2m,-0.008,0.0,0.0,0.0,0.0,0.0,0.0,Folate mitochondrial
MTHFDm,-0.008,0.0,0.0,0.0,0.0,0.0,0.0,Folate mitochondrial
MTPC14_MitoCore,0.27615281967969013,0.2841725407356587,0.2792392555862951,0.28417254073565784,0.27923925558629503,0.24491407312985192,0.20818472069813368,FA metabolism
MTPC16_MitoCore,0.27615281967969013,0.2841725407356587,0.2792392555862951,0.28417254073565784,0.27923925558629503,0.24491407312985192,0.20818472069813368,FA metabolism
NABTNOm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Arginine degradation
NADHt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADHtm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADtm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NDPK1,-3.7280000000000673,-3.7280000000001037,-1.81,-3.728000000000234,-1.81,-3.632595665634663,-1.714736842105263,Cytosolic misc
NDPK1m,-1000.0,-1000.0,0.0,-1000.0,0.0,-1000.0,0.0,TCA cycle periphery
NDPK3m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
NH4t3r,-0.32199999999999995,-0.314,-0.31400000000000006,-0.3139999999999999,-0.314,-0.2532910663086191,-0.2532910663086193,Boundary Conditions - Biomarkers
NNT_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
NOS1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,NOS Signalling
NOS2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,NOS Signalling
NOt,-0.3299999999999952,-0.32199999999999984,-0.32199999999999307,-0.32200000000000184,-0.322,-0.2612910663086192,-0.2612910663086221,Boundary Conditions - Misc
O2t,15.647999322415655,15.648742353897763,15.648415749582927,15.648742353897656,15.64841574958297,11.076158160212428,10.237314971543343,Boundary conditions - core
O2tm,15.632929049836969,15.637073798927663,15.636747194612841,15.6370737989276,15.636747194612903,11.06739276652383,10.228487710309182,Mitochondrial transport - diffusion / artificial
OAAt_MitoCore,-1.917999999999999,-1.9180000000000876,-1.9179999999999988,-1.9179999999999984,-1.91800000000011,-1.9178588235294152,-1.9178588235294107,Boundary Conditions - Biomarkers
OCBTm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Citrulline biosynthesis
OCOAT1m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Ketone bodies - degradation
OF_ATP_MitoCore,80.71384309772483,80.69939875363183,80.7057478589096,80.69939875363181,80.7057478589096,57.25102746637582,53.19365507089719,Objective Function - ATP 
OF_HEME_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Objective Function - Heme
OF_LIPID_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Objective Function - Lipid synthesis 
OF_PROTEIN_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Objective Function - Protein Synthesis
OIVD1m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Leucine degradation
OIVD2m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Valine degradation
OIVD3m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Isoleucine degradation
ORNDC,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
ORNTArm,-0.3229999999999841,-0.3149999999999956,-0.15400000000000003,-0.315,-0.15400000000000139,-0.25429106630862075,-0.12364553315430965,Ornithine degradation
ORNt3mB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
ORNt4mB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
P5CRm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Proline synthesis
P5CRxm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Proline synthesis
PCFLOPm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transport - lipids
PCHOLHSTDe,-6.521916586773431,-6.5152091195091115,0.0,-6.515209119509097,0.0,-4.069906520452903,0.0,Boundary Conditions - Lipids
PCHOLPm_hs,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
PCLAD,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
PCREATtmdiffirB_MitoCore,-922.4171107519619,-922.4167360230203,-920.5439776042731,-922.4167360230206,-920.5439776042731,-945.8293261420729,-948.1047123298117,Mitochondrial transport - diffusion / artificial
PCm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
PDHm,0.0,0.0,0.0,0.0,0.0,0.32569364812244994,0.0,TCA cycle
PEFLIPm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transport - lipids
PEPCK,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Gluconeogenesis
PEPCKm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,TCA cycle periphery
PEt,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Lipids
PFK,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glycolysis
PGCD,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Serine and glycine biosynthesis
PGI,-1.308578947368415,-0.2513333333333255,0.0,-0.2513333333333333,0.0,-0.20894862296032524,0.0,Glycolysis/gluconeogenesis
PGK,-1.81,-1.81,-1.81,-1.81,-1.81,-1.714736842105263,-1.714736842105263,Glycolysis/gluconeogenesis
PGL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Pentose phosphate pathway
PGM,-1.81,-1.81,-1.81,-1.81,-1.81,-1.714736842105263,-1.714736842105263,Glycolysis/gluconeogenesis
PGPPTm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
PGPP_hsm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cardiolipin synthesis
PHEMEtm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
PHEtec,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
PIt2mB_MitoCore,-335.04528055060746,-334.97623614576906,-334.91177525661965,-334.97623614576895,-334.9117752566202,-239.53450746154266,-221.65459460884406,Mitochondrial transporters - characterised
PPA,0.2770319725760949,0.2842607946290907,0.2801372684086964,0.2842607946291419,0.28013726840869624,0.24491407312983965,0.20818472069813512,Carnitine shuttle
PPAm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Carnitine shuttle
PPAt,-1.9499999999999265,-0.03199999999999334,-1.9499999999999922,-0.032,-1.9500000000001094,-0.013765121141308888,-1.5979873254894694,Boundary Conditions - Biomarkers
PPAtmB_MitoCore,-1.9499999999999487,-0.03199999999999545,-1.9499999999999433,-0.03199999999999545,-1.9499999999999469,-0.01376512114131103,-1.5979873254894907,Mitochondrial transporters - uncharacterised
PPBNGS,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
PPCOACm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Propanoate metabolism
PPD2CSPc_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
PPPGOmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
PROD2mB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Proline degradation
PROt2r,-0.3259999999999982,-0.31800000000000006,-0.31800000000000006,-0.31800000000000006,-0.31800000000010653,-0.2572910663086193,-0.25729106630862786,Boundary conditions - nonessential amino acids
PROtm,-0.3259999999998814,-0.3179999999998273,-0.31800000000011863,-0.31799999999988904,-0.3179999999998963,-0.25729106630862664,-0.2572910663085528,Mitochondrial transporters - uncharacterised
PSERT,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Serine and glycine biosynthesis
PSFLIPm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transport - lipids
PSP_L,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Serine and glycine biosynthesis
PSt3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Lipids
PTRCAT1m_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Arginine degradation
PTRCOX1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
PYK,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glycolysis/gluconeogenesis
PYRt2m,0.0,0.0,0.0,0.0,0.0,0.3021837266145757,0.0,Mitochondrial transporters - characterised
R03103_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
RE1254C,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
RE2649M,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Propanoate synthesis
RPE,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Pentose phosphate pathway
RPI,-0.7062500000000004,-0.12566666666666668,0.0,-0.12566666666666668,0.0,-0.10447431148016557,0.0,Pentose phosphate pathway
SACCD3m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
SO3t_MitoCore,-0.0059999999999954525,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
SPODMm,0.010047104915492237,0.010035054827288262,0.010039586746913806,0.010035054827288144,0.010039586746914037,0.0068451963397319245,0.006718587016366727,ROS defense
SUCCt2m,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
SUCCt3m_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
SUCOAS1m,-1000.0,-1000.0,0.0,-1000.0,0.0,-1000.0,0.0,TCA cycle
SUCOASm,-1000.0,-1000.0,-7.243739130434781,-1000.0,-7.24373913043478,-1000.0,-3.973791948153337,TCA cycle
SUMt_MitoCore,-1.9179999999999975,-1.9180000000000348,-1.9179999999999957,-1.9179999999999924,-1.9180000000001085,-1.5473911994410534,-1.797250005389301,Boundary Conditions - Biomarkers
TALA,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Pentose phosphate pathway
TCYNTt,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
TCYNTtmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transport - diffusion / artificial
THRD_L,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Threonine degradation
TKT1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Pentose phosphate pathway
TKT2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Pentose phosphate pathway
TPI,-1.3671747728515014,-1.351650107202592,0.0,-1.3516501072025902,0.0,-0.29011811820738975,0.0,Glycolysis/gluconeogenesis
TRPO2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
TRPt,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
TRPtm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
TSULt_MitoCore,-0.0059999999999954525,-0.006,-0.006,-0.006,-0.006,-0.006,-0.006000000000004334,Boundary Conditions - Misc
TYRTA,-0.30699999999999994,-0.29900000000000015,-0.2989999999999955,-0.29899999999998605,-0.29899999999999416,-0.23843224277921604,-0.2384322427792075,Tyrosine degradation
TYRTB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tyrosine degradation
TYRt,-0.012,-0.012,-0.012,-0.012,-0.012,-0.0118588235294118,-0.0118588235294118,Boundary conditions - nonessential amino acids
UPP3S,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
UPPDC1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Haem Synthesis
URCN,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Histidine degradation
UREAt,-0.33700000000010916,-0.32900000000000273,-0.329,-0.32899999999999996,-0.329,-0.26829106630861876,-0.26829106630862143,Boundary Conditions - Biomarkers
UREAtm,-0.3369999999998754,-0.3289999999998372,-0.3289999999998372,-0.3289999999998372,-0.3289999999998372,-0.2682910663086253,-0.2682910663086193,Mitochondrial transporters - uncharacterised
VALTAm,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Valine degradation
VALt5m,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
VALtec,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
r0060,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Serine degradation
r0074,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Proline / ornithine degradation
r0081,-414.7784714744202,-414.704243595052,-414.73687094161886,-414.70424359505057,-414.7368709416188,-294.90382590829626,-273.3552830032216,TCA cycle periphery
r0122,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glycolysis
r0127,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Asparagine degradation
r0129,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glutathione degradation
r0178,0.0,0.0,0.0,0.0,0.0,0.0,0.0,GABA shunt
r0193,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation III
r0205,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Glycerol phosphate shuttle
r0226,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Folate mitochondrial
r0287,0.2761528196797053,0.284172540735659,0.2792392555862953,0.28417254073565856,0.27923925558629503,0.24491407312985192,0.20818472069813368,FA metabolism
r0399,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Phenylalanine degradation
r0450,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
r0464c_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
r0514,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Folate mitochondrial
r0525,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
r0541,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan / Lysine Metabolism 
r0560,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Valine degradation
r0594,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
r0595B_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation II
r0595m_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Cysteine degradation II
r0603,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Isoleucine degradation
r0633,-16.45671468190383,-16.45062872663827,-9.141912732421059,-16.450628726638275,-9.141912732421059,-4.284814924147645,-2.381149362863159,Fatty acid elongation in mitochondria
r0634,-1.067934782608696,-1.0,-1.054391304347825,-1.0,-1.0543913043478261,-0.3835616438356164,-0.4044240619416318,FA metabolism
r0638,-16.456714681903893,-16.45062872663828,-9.141912732421059,-16.45062872663829,-9.141912732421059,-4.284814924147646,-2.381149362863159,Fatty acid elongation in mitochondria
r0645,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
r0655,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Leucine degradation
r0660,-1.0679347826087024,-1.0,-1.0543913043478255,-1.0,-1.054391304347826,-0.3835616438356162,-0.4044240619416315,FA metabolism
r0678,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0681,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0682,-0.2442857142857143,0.0,-0.24428571428571427,0.0,-0.2442857142857142,0.0,-0.1793206719924573,FA synthesis - cytosolic
r0691,-0.24428571428571427,0.0,-0.24428571428571424,0.0,-0.24428571428571433,0.0,-0.17932067199245758,FA synthesis - cytosolic
r0692,-0.24428571428571427,0.0,-0.24428571428571427,0.0,-0.24428571428571427,0.0,-0.17932067199245824,FA synthesis - cytosolic
r0693,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0694,-0.24428571428571427,0.0,-0.24428571428571427,0.0,-0.2442857142857143,0.0,-0.17932067199245835,FA synthesis - cytosolic
r0695,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0696,-0.24428571428571422,0.0,-0.24428571428571433,0.0,-0.24428571428571427,0.0,-0.17932067199245721,FA synthesis - cytosolic
r0697,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0701,-0.24428571428571427,0.0,-0.2442857142857143,0.0,-0.24428571428571424,0.0,-0.17932067199245721,FA synthesis - cytosolic
r0702,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0712,-0.24428571428571427,0.0,-0.2442857142857143,0.0,-0.24428571428571427,0.0,-0.17932067199245721,FA synthesis - cytosolic
r0713,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0722,0.27615281967969946,0.2841725407356588,0.2792392555862952,0.2841725407356583,0.2792392555862949,0.24491407312985194,0.20818472069813368,FA metabolism
r0724,-1.0679347826086931,-1.0,-1.0543913043478261,-1.0,-1.0543913043478264,-0.3835616438356164,-0.4044240619416318,FA metabolism
r0726,0.27615281967970273,0.28417254073565873,0.2792392555862951,0.28417254073565856,0.27923925558629503,0.24491407312985192,0.20818472069813368,FA metabolism
r0728,-1.0679347826086996,-1.0,-1.0543913043478277,-1.0,-1.0543913043478264,-0.3835616438356162,-0.40442406194163194,FA metabolism
r0730,0.2761528196797053,0.284172540735659,0.2792392555862952,0.28417254073565856,0.27923925558629503,0.24491407312985192,0.20818472069813368,FA metabolism
r0731,0.27615281967970523,0.28417254073565873,0.27923925558629537,0.28417254073565884,0.27923925558629537,0.24491407312985192,0.20818472069813368,FA metabolism
r0732,0.2761528196797053,0.284172540735659,0.2792392555862952,0.28417254073565856,0.27923925558629503,0.24491407312985192,0.20818472069813368,FA metabolism
r0733,0.2761528196797053,0.284172540735659,0.2792392555862953,0.28417254073565856,0.27923925558629503,0.24491407312985192,0.20818472069813368,FA metabolism
r0734,0.2761528196797053,0.284172540735659,0.2792392555862953,0.28417254073565856,0.27923925558629503,0.24491407312985192,0.20818472069813368,FA metabolism
r0735,-16.456714681903705,-16.450628726638268,-9.141912732421059,-16.450628726638268,-9.141912732421059,-4.284814924147645,-2.381149362863159,Fatty acid elongation in mitochondria
r0760,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0761,-0.2442857142857143,0.0,-0.24428571428571427,0.0,-0.2442857142857142,0.0,-0.17932067199245907,FA synthesis - cytosolic
r0762,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0763,-0.24428571428571427,0.0,-0.24428571428571424,0.0,-0.2442857142857143,0.0,-0.1793206719924573,FA synthesis - cytosolic
r0764,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0765,-0.24428571428571427,0.0,-0.24428571428571427,0.0,-0.24428571428571427,0.0,-0.17932067199245885,FA synthesis - cytosolic
r0766,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0767,-0.24428571428571427,0.0,-0.24428571428571433,0.0,-0.24428571428571427,0.0,-0.17932067199245721,FA synthesis - cytosolic
r0768,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0769,-0.24428571428571427,0.0,-0.24428571428571433,0.0,-0.24428571428571427,0.0,-0.17932067199245721,FA synthesis - cytosolic
r0770,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0771,-0.24428571428571424,0.0,-0.24428571428571433,0.0,-0.24428571428571427,0.0,-0.1793206719924576,FA synthesis - cytosolic
r0772,0.0,0.0,0.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0773,-0.24428571428571424,0.0,-0.24428571428571466,0.0,-0.24428571428571422,0.0,-0.1793206719924575,FA synthesis - cytosolic
r0791,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
r0817,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
r0829,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r0830,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r0830B_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r0838B_MitoCore,-26.255154467151044,-26.250515224690567,-26.22855443385182,-26.25051522469162,-26.2285544338517,-18.614411313270544,-17.358377348352704,Mitochondrial transport - diffusion / artificial
r0899,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
r0913,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r0917,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r0917b_MitoCore,-74.66030486539546,-74.64694384710916,-74.65281676949104,-74.64694384710924,-74.65281676949114,-52.957200406397156,-49.20413094057981,Mitochondrial transporters - characterised
r0940,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
r0941,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transport - diffusion / artificial
r0942,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
r0942b_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
r0962B_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1078,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1088,-1.9179999999999997,-1.9179999999999837,-1.9179999999999955,-1.9179999999999988,-1.9180000000001094,-1.1541747364954986,-1.414376454648155,Boundary Conditions - Biomarkers
r1154,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Threonine and Methionine degradation
r1155,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Threonine degradation
r1423,-0.3101086423609414,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
r1427,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r1434,-414.7784714744133,-414.7042435950463,-414.73687094161534,-414.70424359504835,-414.73687094161835,-294.903825908289,-273.355283003228,Mitochondrial transporters - uncharacterised
r1435,-0.3589999999998964,-0.13233333333328057,-0.3429999999998964,-0.13233333333329886,-0.3430000000000025,-0.0715163120567376,-0.1853659574468086,Mitochondrial transporters - uncharacterised
r1436,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1437,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1440,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1446,0.27743934234113377,0.28545906339708715,0.2805257782477244,0.2854590633970877,0.2805257782477241,0.24620059579128067,0.20947124335956221,FA metabolism
r1447,0.27615281967969013,0.2841725407356587,0.2792392555862951,0.28417254073565784,0.27923925558629503,0.24491407312985192,0.20818472069813368,FA metabolism
r1448,0.2761528196797033,0.28417254073565873,0.2792392555862953,0.2841725407356588,0.2792392555862949,0.2449140731298522,0.20818472069813368,FA metabolism
r1450,0.2761528196797053,0.284172540735659,0.2792392555862952,0.28417254073565856,0.27923925558629503,0.24491407312985192,0.20818472069813368,FA metabolism
r1451,0.27615281967966393,0.2841725407356589,0.2792392555862953,0.2841725407356588,0.279239255586295,0.2449140731298522,0.20818472069813368,FA metabolism
r1455,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1512,-0.08887500000000001,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
r2398B_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r2402B_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r2435,0.27615281967971267,0.2841725407356588,0.2792392555862953,0.28417254073565784,0.27923925558629414,0.2449140731298522,0.20818472069813512,Carnitine shuttle
r2525,-0.33000000000006546,-0.322,-0.322,-0.322,-0.32199999999999684,-0.26129106630862076,-0.2612910663086189,Boundary conditions - nonessential amino acids
r2526,-0.3385,-0.3265,-0.3265,-0.3265,-0.3264999999999931,-0.26529106630861926,-0.2652910663086193,Boundary conditions - nonessential amino acids
r2532,-0.31999999999999545,-0.312,-0.3119999999999996,-0.312,-0.3120000000001042,-0.2512910663086193,-0.2512910663086174,Boundary conditions - nonessential amino acids
r2534,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
